IDT Biologika has announced plans to expand its viral vaccine production capacity with the addition of a new high-speed filling line and additional lyophilization capacity. The company also announced the addition of 80 employees to its workforce — a boost of 11 % — to meet growth in demand for biologics production. The company plans to expand its flexible, multipurpose vaccine manufacturing facilities via the completion of its new high-speed viral vaccine line by mid-2013. This line will subs...